E-LIB Suche - Ergebnisse für: Maike Voges

1

Preclinical toxicity analyses of lentiviral vectors express..:

Beschorner, Niklas ; Künzle, Paul ; Voges, Maike...
PLOS ONE. 19 (2024) 3 - p. e0298542 , 2024

Link: https://doi.org/10.1371/..

2

Interaction between the cellular E3 ubiquitin ligase SIAH-1..:

Czechowicz, Julia S. ; Nagel, Claus-Henning ; Voges, Maike...
PLOS ONE. 13 (2018) 8 - p. e0201880 , 2018

Link: https://doi.org/10.1371/..

3

O5 CRISPR/Cas9-derived activation systems as new tools for ..:

Bialek, JuliaK ; Voges, Maike ; Dunay, Gabor A....
Journal of Virus Eradication. 2 (2016) - p. 2 , 2016

Link: https://doi.org/10.1016/..

4

Abolishing HIV-1 infectivity using a polypurine tract-speci..:

Voges, Maike ; Schneider, Carola ; Sinn, Malte...
BMC Infectious Diseases. 16 (2016) 1 - p. , 2016

Link: https://doi.org/10.1186/..

5

Targeted HIV-1 Latency Reversal Using CRISPR/Cas9-Derived T..:

Bialek, Julia K. ; Dunay, Gábor A. ; Voges, Maike...
PLOS ONE. 11 (2016) 6 - p. e0158294 , 2016

Link: https://doi.org/10.1371/..

6

Extracellular IgC2 Constant Domains of CEACAMs Mediate PI3K..:

Voges, Maike ; Bachmann, Verena ; Naujoks, Jan...
PLoS ONE. 7 (2012) 6 - p. e39908 , 2012

Link: https://doi.org/10.1371/..

7

Phosphatidylinositol 3′-Kinase Activity Is Critical for Ini..:

Buntru, Alexander ; Kopp, Kathrin ; Voges, Maike...
Journal of Biological Chemistry. 286 (2011) 11 - p. 9555-9566 , 2011

Link: https://doi.org/10.1074/..

8

CEACAM1 recognition by bacterial pathogens is species-speci..:

Voges, Maike ; Bachmann, Verena ; Kammerer, Robert..
BMC Microbiology. 10 (2010) 1 - p. , 2010

Link: https://doi.org/10.1186/..

9

Interaction between the cellular E3 ubiquitin ligase SIAH-1..:

Julia S Czechowicz ; Claus-Henning Nagel ; Maike Voges...
http://europepmc.org/articles/PMC6078308?pdf=render. , 2018

Link: https://doi.org/10.1371/..

10

O5 CRISPR/Cas9-derived activation systems as new tools for ..:

JuliaK Bialek ; Maike Voges ; Gabor A. Dunay...
http://www.sciencedirect.com/science/article/pii/S2055664020310840. , 2016

Link: https://doi.org/10.1016/..

11

Targeted HIV-1 Latency Reversal Using CRISPR/Cas9-Derived T..:

Julia K Bialek ; Gábor A Dunay ; Maike Voges...
http://europepmc.org/articles/PMC4920395?pdf=render. , 2016

Link: https://doi.org/10.1371/..

12

Extracellular IgC2 constant domains of CEACAMs mediate PI3K..:

Maike Voges ; Verena Bachmann ; Jan Naujoks..
http://europepmc.org/articles/PMC3386982?pdf=render. , 2012

Link: https://doi.org/10.1371/..

13

Abolishing HIV-1 infectivity using a polypurine tract-speci..:

Voges, Maike ; Schneider, Carola ; Sinn, Malte...
https://repository.publisso.de/resource/frl:6403692. , 2016

Link: https://repository.publi..

14

Abolishing HIV-1 infectivity using a polypurine tract-speci..:

Voges, Maike ; Schneider, Carola ; Sinn, Malte...
http://www.biomedcentral.com/1471-2334/16/358. , 2016

Link: http://www.biomedcentral..

15

Targeted HIV-1 Latency Reversal Using CRISPR/Cas9-Derived T..:

Bialek, Julia K ; Dunay, Gábor A ; Voges, Maike...
https://repository.publisso.de/resource/frl:6403788. , 2016

Link: https://repository.publi..